Prestige Brands recalls Clear Eyes Maximum Itchy Eye Relief due to contamination concerns
Category: Health
Nearly 40,000 bottles of Clear Eyes Maximum Itchy Eye Relief eye drops are being recalled across the United States due to potential contamination issues. The U.S. Food and Drug Administration (FDA) reported that the recall was initiated voluntarily by Prestige Brands Holdings, which cited a "lack of assurance of sterility" as the primary reason for the action.
The recall involves 39,060 bottles of the eye drops, which are packaged in 15 mL (0.5 fl oz) dropper bottles. The affected products have an expiration date of September 30, 2027, and are identifiable by their lot code 2552A, NDC 67172-999-01, and UPC 6 78112 65920 3. Consumers should be particularly cautious, as the FDA has classified this recall as a Class II, indicating that exposure to the product could lead to temporary or medically reversible health consequences, though serious adverse effects are unlikely.
This recall was initiated on July 29, 2026, and the FDA's classification of the recall was updated on August 14, 2026, indicating that it is still an active concern for consumers. The eye drops were distributed nationwide, making it important for anyone who may have purchased them to check their medicine cabinets.
If you have purchased the recalled Clear Eyes Maximum Itchy Eye Relief eye drops, it is advised that you stop using them immediately. The FDA emphasizes that the contaminated drops could pose a risk of infection, which is particularly concerning for individuals with pre-existing eye conditions or weakened immune systems.
Consumers can typically return the affected products to the place of purchase for a refund or exchange. If you are unsure about the return policy, it’s best to contact your local retailer directly to inquire about your options. The FDA has provided guidance for consumers on how to handle recalled products, encouraging them to dispose of any unused portions safely.
Prestige Brands Holdings is a well-known consumer healthcare company headquartered in Tarrytown, New York. The company markets a variety of over-the-counter products, including Dramamine for motion sickness, Breathe Right nasal strips, and Monistat for feminine hygiene. This recall shows the value of maintaining strict quality controls in the manufacturing process, especially for products intended for sensitive areas such as the eyes.
In light of this recall, it’s worth noting that this is not the first time eye drops have faced scrutiny over sterility issues. Earlier in August, another company, Vietnam-based Rohto-Mentholatum Co., Ltd., recalled over 11.9 million cartons of its eye drops due to similar concerns, prompting increased vigilance among consumers and regulators alike.
The FDA plays a key role in ensuring the safety of consumer products, including over-the-counter medications like eye drops. Their classification of recalls helps inform the public about the potential risks associated with certain products. Class II recalls, like the one involving Clear Eyes, are particularly important as they indicate that there may be some risk, but not one that is likely to lead to serious health consequences.
Consumers are encouraged to stay informed about product recalls and to report any adverse reactions they may experience after using a recalled product. The FDA provides resources for consumers to check for recalls on their website, making it easier to stay updated on product safety.
For those who may have questions about the recall or potential health impacts, contacting a healthcare provider is always a prudent choice. They can provide personalized advice based on individual health needs and circumstances.
As consumers navigate this recall, it is important to prioritize safety and stay informed about the products they use. Regularly checking for updates from the FDA and other health authorities can help mitigate risks associated with contaminated products.
For those who may have purchased the recalled eye drops, it is best to act quickly and responsibly. The FDA’s commitment to consumer safety remains a priority, and staying informed is the best way to protect oneself and one’s family from potential health risks.